Contract 36C24E21P0162
New York Genome Center, Inc. · Department Of Veterans Affairs · September 22, 2021
New York Genome Center, Inc. was awarded a federal contract by Department Of Veterans Affairs on September 22, 2021 for $68,000 of work in research and development in biotechnology (except nanobiotechnology). Performance is in New York, NY. It was awarded under full and open competition. The contract has been modified 1 time since the base award It uses firm fixed-price contract pricing. The most recent modification was on July 2, 2024.
Contract details
- PIID
- 36C24E21P0162
- Award type
- Purchase Order
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Not Competed
- NAICS
- 541714 · Research And Development In Biotechnology (Except Nanobiotechnology)
- Product / service
- Health R&D Services; Health Care - Other; Basic Research
- Place of performance
- New York, NY
- First action
- September 22, 2021
- Latest action
- July 2, 2024
Description
SEQUENCING SERVICES
Modification timeline
-
July 2, 2024Mod P00001 · Supplemental Agreement For Work Within Scope$68.1K
-
September 22, 2021Base award$75.6K
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| University Of Wisconsin System | Department Of Veterans Affairs | March 31, 2026 | $0 |
| Psomagen Inc | Department Of Veterans Affairs | March 31, 2026 | $7.0K |
| University Of Wisconsin System | Department Of Veterans Affairs | March 30, 2026 | $3.2K |
| University Of Wisconsin System | Department Of Veterans Affairs | March 30, 2026 | $149.2K |
| Northwestern University | Department Of Veterans Affairs | March 27, 2026 | $64.1K |
| University Of Wisconsin System | Department Of Veterans Affairs | March 27, 2026 | $1.3K |
Top contractors in NAICS 541714
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Amgen USA Inc | 1 | $59.99M |
| 2 | Vericel Corporation | 1 | $34.88M |
| 3 | Spectral Md, Inc. | 1 | $31.67M |
| 4 | Ppd Development Lp | 6 | $31.12M |
| 5 | L3 Technologies, Inc. | 1 | $22.00M |
| 6 | Technical Resources International, Inc. | 6 | $21.80M |
| 7 | Abbott Laboratories | 1 | $21.01M |
| 8 | Paratek Pharmaceuticals, Inc | 1 | $17.47M |
| 9 | Ossium Health, Inc. | 1 | $12.39M |
| 10 | Rho Federal Systems Division Inc | 1 | $8.00M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 36C24E21P0162?
Contract 36C24E21P0162 is a federal contract awarded to New York Genome Center, Inc. by Department Of Veterans Affairs on September 22, 2021 for $68,000 of work classified under RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY). It has been modified 1 time since the base award.
Who won contract 36C24E21P0162?
New York Genome Center, Inc. won contract 36C24E21P0162 from Department Of Veterans Affairs.
How much is contract 36C24E21P0162 worth?
Contract 36C24E21P0162 has obligated $68,000 to date.